Ailsa Brown | Lead Health Economist
Scottish Medicines Consortium

Ailsa Brown, Lead Health Economist, Scottish Medicines Consortium

Appearances:



World Orphan Drug Congress USA 2019 - Day 1 @ 15:40

SCOTLAND: Improved Access - allowing three years of patient access to medicines for ultra-rare conditions in NHS Scotland and creating the opportunity to collect real-world data for reimbursement

last published: 24/Mar/19 01:45 GMT

back to speakers